Article
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
GLP-1 RAs Linked to BMI-Dependent Heart Benefits in Type 2 Diabetes
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes
How Can Employers Leverage the DPP to Improve Diabetes Rates?
METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes
Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk